CHS430

ICU Pneumonia Detection in Minutes

ICU_CHS430

RAPID DECTION IN THE CRITICAL MOMENTS

CHS430 detects ventilator-associated pneumonia (VAP)
in 10 minutes or less.

Through rapid testing, CHS430 identifies early signs of VAP and alert specialists
in the critical window before complications arise.  

Hospital_CHS430

Faster bacteria identification allows doctors to select the right treatment path earlier.

Early identification leads to better patient outcomes and life-saving conditions.

HOW IT WORKS

CHS430 intakes breath of intubated patient

CHS430 intakes
breath of intubated
patient 

Pathogens are identified in 10 minutes

Pathogens are identified in 10 minutes 

Doctors prescribe correct antibiotic

Doctors prescribe correct antibiotic 

Better patient outcomes

Better patient outcomes 

VAP: DEADLY INFECTIONS IN THE ICU

Patients in the intensive care unit of a hospital are often at risk from more than just their illness.
Critical life-saving processes can result in healthcare-associated infection (HAI).

2nd_icon
27%_icon
300K_icon

RIGHT TREATMENT AT THE WRONG TIME

Treating VAP requires the right antibiotic for the right strain at the right time. Any mistakes result in patient harm. Early detection reduces the risk of mortality or disease metastasis.  

Every minute counts.

Yet, traditional methods of detection are slow, inconclusive, or invasive.

  •  Sputum examination can take 5-7 days to culture with only 40% of patients successfully diagnosed
  •  Sensitivity of blood cultures is less than 20% and experts suggest multiple blood draws to ensure accuracy
  •  Tracheal border examination and skin thoracic puncture examination are uncomfortable for patients and are highly subjective to diagnostic capabilities
  •  X-rays can confirm infection at later stages but cannot differentiate the bacteria

RAPID DETECTION THROUGH SMELL TECH

CHS430 connects to the y-connector of the respirator
and detects pathogens within minutes.  

robot CHS430

The device quickly screens volatile organic compounds (VOCs) in the patient’s breaths using an AI-powered digital nose.

Specialized sensors and algorithms quick identify the four most common bacterial species related to VAP.

This is completely non-invasive, rapid, and reliable.

Early trials and studies have shown over 80% recognition rates of VAP.
Ainos aims to remove VAP from the top 10 causes of death in critical care situations. 

CONTACT US

United States:

8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108

 +1 (858) 869-2986

Taiwan:

10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.)

 +886 (0)3-550-5199